Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient
Abstract Background Although shoulder arthroplasty is less common than knee or hip arthroplasty, the number of procedures being performed is increasing rapidly. The treatment effect is a simple method to measure outcome of joint replacement. The method was applied to measure results of total hip/kne...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12891-020-03427-7 |
id |
doaj-fa815aaf5c3c4db387c092bb73386e15 |
---|---|
record_format |
Article |
spelling |
doaj-fa815aaf5c3c4db387c092bb73386e152020-11-25T03:05:23ZengBMCBMC Musculoskeletal Disorders1471-24742020-06-012111810.1186/s12891-020-03427-7Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patientJoerg Huber0Ulrich Irlenbusch1Max J. Kääb2Falk Reuther3Georges Kohut4Andy Judge5Department of Orthopedics, Stadtspital TriemliOrthopedic Clinics, MarienstiftSportorthopädicum StraubingDRK Kliniken KöpenickClinique generaleMusculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning & Research Building, Southmead HospitalAbstract Background Although shoulder arthroplasty is less common than knee or hip arthroplasty, the number of procedures being performed is increasing rapidly. The treatment effect is a simple method to measure outcome of joint replacement. The method was applied to measure results of total hip/knee arthroplasty but not yet for shoulder arthroplasty. Methods Included were patients with unilateral cuff arthropathy (Hamada grades > = 2) treated with reversed total shoulder arthroplasty (RSA) in this prospective multicenter study. The patients were assessed with the ASES questionnaire. The treatment effects (TE) was calculated for each patient. TE = score reduction/baseline score. A positive TE means amelioration, TE = 0 unchanged, and a negative TE means worse. The primary aim was to calculate the TE’s for RSA at 6, 12, 24, and 60 months postoperatively. The secondary aim was to analyze the influence of confounders (preoperative Hamada grade, age, gender, dominance, side of the affected shoulder, general co-morbidities measured using ASA grade). Results Two hundred three patients were included for this analysis of whom 183 patients had a complete 2 year follow up. Two years postoperatively the mean ASES score augmented significant from 20.5 to 78.7 (p < 0.001). The 2 year TE’s ranged from 1 to 0.09. We had no patient with a negative TE. A higher Hamada grade was associated with better TE’s (Hamada grade 4+ vs. 2, p-value 0.042). For age and dominant side there were weak associations where those aged 80+ and dominant side had better TE’s. The patients with higher ASA grade had lower TE’s (ASA grade 4+ vs. 1, p-value 0.013). The mean TE’s were 0.77 at 6-months, 0.81 at 1 year, 0.76 at 2 years and 0.73 at 5 years. Conclusions The outcome for reverse shoulder arthroplasty can be measured with the treatment effect method; the 2 years TE’s vary from 1 to 0.09. The mean treatment effects change little in the first five postoperative years (from 0.73 to 0.81). The confounders for better TE’s were: higher severity of cuff arthropathy (Hamada grade 3, 4 and 5), less co-morbidities (ASA Grade 1), higher age (80+) and dominant side. Gender did not influence the 2-year TE’s. Trial registration Comité intercantonal d’éthique (Jura, Fribourg, Neuchâtel), number 01/2008, 24.09.2008.http://link.springer.com/article/10.1186/s12891-020-03427-7Cuff arthropathyReverse shoulder arthroplastyTreatment effectOutcomeConfounders |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joerg Huber Ulrich Irlenbusch Max J. Kääb Falk Reuther Georges Kohut Andy Judge |
spellingShingle |
Joerg Huber Ulrich Irlenbusch Max J. Kääb Falk Reuther Georges Kohut Andy Judge Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient BMC Musculoskeletal Disorders Cuff arthropathy Reverse shoulder arthroplasty Treatment effect Outcome Confounders |
author_facet |
Joerg Huber Ulrich Irlenbusch Max J. Kääb Falk Reuther Georges Kohut Andy Judge |
author_sort |
Joerg Huber |
title |
Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient |
title_short |
Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient |
title_full |
Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient |
title_fullStr |
Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient |
title_full_unstemmed |
Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient |
title_sort |
treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient |
publisher |
BMC |
series |
BMC Musculoskeletal Disorders |
issn |
1471-2474 |
publishDate |
2020-06-01 |
description |
Abstract Background Although shoulder arthroplasty is less common than knee or hip arthroplasty, the number of procedures being performed is increasing rapidly. The treatment effect is a simple method to measure outcome of joint replacement. The method was applied to measure results of total hip/knee arthroplasty but not yet for shoulder arthroplasty. Methods Included were patients with unilateral cuff arthropathy (Hamada grades > = 2) treated with reversed total shoulder arthroplasty (RSA) in this prospective multicenter study. The patients were assessed with the ASES questionnaire. The treatment effects (TE) was calculated for each patient. TE = score reduction/baseline score. A positive TE means amelioration, TE = 0 unchanged, and a negative TE means worse. The primary aim was to calculate the TE’s for RSA at 6, 12, 24, and 60 months postoperatively. The secondary aim was to analyze the influence of confounders (preoperative Hamada grade, age, gender, dominance, side of the affected shoulder, general co-morbidities measured using ASA grade). Results Two hundred three patients were included for this analysis of whom 183 patients had a complete 2 year follow up. Two years postoperatively the mean ASES score augmented significant from 20.5 to 78.7 (p < 0.001). The 2 year TE’s ranged from 1 to 0.09. We had no patient with a negative TE. A higher Hamada grade was associated with better TE’s (Hamada grade 4+ vs. 2, p-value 0.042). For age and dominant side there were weak associations where those aged 80+ and dominant side had better TE’s. The patients with higher ASA grade had lower TE’s (ASA grade 4+ vs. 1, p-value 0.013). The mean TE’s were 0.77 at 6-months, 0.81 at 1 year, 0.76 at 2 years and 0.73 at 5 years. Conclusions The outcome for reverse shoulder arthroplasty can be measured with the treatment effect method; the 2 years TE’s vary from 1 to 0.09. The mean treatment effects change little in the first five postoperative years (from 0.73 to 0.81). The confounders for better TE’s were: higher severity of cuff arthropathy (Hamada grade 3, 4 and 5), less co-morbidities (ASA Grade 1), higher age (80+) and dominant side. Gender did not influence the 2-year TE’s. Trial registration Comité intercantonal d’éthique (Jura, Fribourg, Neuchâtel), number 01/2008, 24.09.2008. |
topic |
Cuff arthropathy Reverse shoulder arthroplasty Treatment effect Outcome Confounders |
url |
http://link.springer.com/article/10.1186/s12891-020-03427-7 |
work_keys_str_mv |
AT joerghuber treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient AT ulrichirlenbusch treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient AT maxjkaab treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient AT falkreuther treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient AT georgeskohut treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient AT andyjudge treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient |
_version_ |
1724678889429532672 |